ARCHIVES

Mihich Recommendation for Antigen Development In BRMP Summarized

This article is from The Cancer Letter archive.

Vol. 05 No. 50 | December 14, 1979

Download PDF Visit The Full Archive

Related Articles

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Report Outlines “Grand Challenges” For Chemistry

March 7, 2003

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Committee Unblinds Phase III Zytiga Study

March 30, 2012